Ann: Business Update, page-78

A US listing would certainly change the context in which this business is analyzed. Most investors here are comparing this to other ASX microcaps, when it should be compared to other global chemical ingredients companies.

I came across this data this morning, showing the relative strength and high valuations in ANO's category vs other chemical companies. A US listing will demand the attention of other industry specialists, who will immediately notice that margins and growth are way higher than average yet valuation is roughly in line.